The U.S. Food and Drug Administration (FDA) is proposing to phase out phenylephrine, a common decongestant found in many over-the-counter medications, due to concerns about its effectiveness.
WASHINGTON - Changes are coming to the cold and cough aisle of your local pharmacy: U.S. officials are moving to phase out the leading decongestant found in hundreds of over-the-counter medicines, concluding that it doesn't actually relieve nasal congestion. Phenylephrine is used in popular versions of Sudafed, Dayquil and other medications, but experts have long questioned its effectiveness.
Last month the Food and Drug Administration formally proposed revoking its use in pills and liquid solutions, kicking off a process that's likely to force drugmakers to remove or reformulate products. It's a win for skeptical academics, including researchers at the University of Florida who petitioned the FDA to revisit the drug's use in 2007 and again in 2015. For consumers it will likely mean switching to alternatives, including an older decongestant that was moved behind the pharmacy counter nearly 20 years ago
PHENCYLEPHRINE DECONGESTANT FDA COLD MEDICINES OVER-THE-COUNTER DRUGS PHARMACY
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
El Salvador president proposes ending country's metals mining banEl Salvador President Nayib Bukele has proclaimed himself in favor of mining gold in the Central America country and called his nation’s 7-year-old ban on metals mining “absurd.” It immediately puts in jeopardy the historic prohibition.
Read more »
Lenny Hochstein re-proposes to Katharina Mazepa 4 months after ending first engagement“Sometimes life gives you a second chance and you realize what truly matters,” Hochstein announced via Instagram alongside two photos of the at-home proposal.
Read more »
FDA To Ban Off-Brand Weight Loss Drugs, Ending Copycat CompetitionThe FDA has ruled that specialty pharmacies and online companies selling off-brand versions of the popular weight loss drugs Zepbound and Mounjaro must stop next year. This decision, a victory for drug maker Lilly, stems from the resolution of a dispute regarding intellectual property rights.
Read more »
MLB Analyst Proposes Interesting Trade Idea Involving Reds Top Prospect Rhett LowderMLB Analyst Proposes Interesting Trade Idea Involving Cincinnati Reds Top Prospect Rhett Lowder
Read more »
US agency proposes to streamline self-driving car exemption reviewsUS agency proposes to streamline self-driving car exemption reviews
Read more »
FDA to Phase Out Common DecongestantThe FDA is taking action against phenylephrine, a common decongestant found in many over-the-counter medications, due to concerns about its effectiveness.
Read more »